🦴 Luna/Emily 🐾
@blueberryonthemoon.bsky.social
Reposted by 🦴 Luna/Emily 🐾
GOOD NEWS! Moderna’s combination COVID/influenza vaccine candidate mRNA-1083 has OUTPERFORMED the current standalone vaccines for BOTH viruses in a large (8000+) Phase III trial. A combination vaccine would make it easier for people to get vaccinated against COVID and influenza at the same time. 🧪🧵⬇️
May 11, 2025 at 4:01 PM
GOOD NEWS! Moderna’s combination COVID/influenza vaccine candidate mRNA-1083 has OUTPERFORMED the current standalone vaccines for BOTH viruses in a large (8000+) Phase III trial. A combination vaccine would make it easier for people to get vaccinated against COVID and influenza at the same time. 🧪🧵⬇️
Reposted by 🦴 Luna/Emily 🐾
Since we can’t rely on the HHS, CDC, or FDA to say it, I will:
MAKE SURE YOU ARE VACCINATED AGAINST MEASLES. GET YOUR MMR.
The measles surge in the southwest is now the SINGLE LARGEST OUTBREAK since 2000 and the United States is now at the tipping point for the return of ENDEMIC measles.
MAKE SURE YOU ARE VACCINATED AGAINST MEASLES. GET YOUR MMR.
The measles surge in the southwest is now the SINGLE LARGEST OUTBREAK since 2000 and the United States is now at the tipping point for the return of ENDEMIC measles.
April 24, 2025 at 7:21 PM
Since we can’t rely on the HHS, CDC, or FDA to say it, I will:
MAKE SURE YOU ARE VACCINATED AGAINST MEASLES. GET YOUR MMR.
The measles surge in the southwest is now the SINGLE LARGEST OUTBREAK since 2000 and the United States is now at the tipping point for the return of ENDEMIC measles.
MAKE SURE YOU ARE VACCINATED AGAINST MEASLES. GET YOUR MMR.
The measles surge in the southwest is now the SINGLE LARGEST OUTBREAK since 2000 and the United States is now at the tipping point for the return of ENDEMIC measles.
Reposted by 🦴 Luna/Emily 🐾
THIS IS HUGE! Researchers at Cornell University have developed a new thermostable, MULTI-TARGET vaccine platform that offers stronger, longer-lasting protection against SARS-CoV-2 AND influenza while providing broader immunity against VARIOUS flu strains. 🧪🧵⬇️
March 13, 2025 at 4:00 PM
THIS IS HUGE! Researchers at Cornell University have developed a new thermostable, MULTI-TARGET vaccine platform that offers stronger, longer-lasting protection against SARS-CoV-2 AND influenza while providing broader immunity against VARIOUS flu strains. 🧪🧵⬇️
Reposted by 🦴 Luna/Emily 🐾
THIS IS HUGE! Researchers at Stanford University have developed a dual-antibody treatment that remains effective against ALL SARS-CoV-2 variants by targeting a less-mutable part of the virus. This breakthrough could lead to longer-lasting therapies that OUTPACE viral evolution. 🧪🧵⬇️
March 9, 2025 at 4:00 PM
THIS IS HUGE! Researchers at Stanford University have developed a dual-antibody treatment that remains effective against ALL SARS-CoV-2 variants by targeting a less-mutable part of the virus. This breakthrough could lead to longer-lasting therapies that OUTPACE viral evolution. 🧪🧵⬇️